I way I look at this company is that its currently valued significantlybelow its replacement cost (very low Q-ratio) and therefore future downside islimited from this point (bear case). My base case is for a steady continuationof improvements in current businesses with share prices returning to cap raiselevels and bull case sees a huge spike once bio-dynamic organic infant formulais announced. Launching into a new niche segment of the IF market with LBsteering the ship will see the hype of 2017 return.
Intrinsic Value, page-15
Add MBH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.4¢ |
Change
0.001(1.20%) |
Mkt cap ! $29.60M | |||
| Open | High | Low | Value | Volume |
| 8.3¢ | 8.5¢ | 8.3¢ | $20.76K | 246.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 529043 | 8.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.5¢ | 669 | 1 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
8.4¢ |
Change
0.001 ( 1.20 %) |
||||
| Open | High | Low | Volume | ||
| 8.4¢ | 8.4¢ | 8.4¢ | 10272 | ||
| Last updated 11.33am 03/06/2024 ? | |||||
| MBH (ASX) Chart |